Romiplostim for anemia, aplastic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 31 Jan 2026: Trial started, NCT07400341
  2. 10 Feb 2026: Trial registered, NCT07400341

The trials

NCT07400341: Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA

State
Under way
Phase
Phase 2
People
66 planned
Started
31 Jan 2026
Primary completion
31 Jan 2028
Arms
Romiplostim
Results
None posted
  1. 31 Jan 2026: Trial started
  2. 10 Feb 2026: Trial registered

NCT07572084: Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia

State
Not started
Phase
Phase 2
People
43 planned
Started
Apr 2026
Primary completion
Dec 2028
Arms
Romiplostim N01
Results
None posted
  1. 7 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Nplate, Romiplate, Romiplostim N01.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.